These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

845 related articles for article (PubMed ID: 33536635)

  • 1. Trends in peptide drug discovery.
    Muttenthaler M; King GF; Adams DJ; Alewood PF
    Nat Rev Drug Discov; 2021 Apr; 20(4):309-325. PubMed ID: 33536635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translational aspect in peptide drug discovery and development: An emerging therapeutic candidate.
    Anand U; Bandyopadhyay A; Jha NK; Pérez de la Lastra JM; Dey A
    Biofactors; 2023 Mar; 49(2):251-269. PubMed ID: 36326181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic peptides: Historical perspectives, current development trends, and future directions.
    Lau JL; Dunn MK
    Bioorg Med Chem; 2018 Jun; 26(10):2700-2707. PubMed ID: 28720325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural peptides to drugs - fourth international congress.
    Leone-Bay A
    IDrugs; 2010 Jun; 13(6):369-71. PubMed ID: 20506056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emergence of the C-H functionalization strategy in medicinal chemistry and drug discovery.
    Jana R; Begam HM; Dinda E
    Chem Commun (Camb); 2021 Oct; 57(83):10842-10866. PubMed ID: 34596175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The emerging role of computational design in peptide macrocycle drug discovery.
    Mulligan VK
    Expert Opin Drug Discov; 2020 Jul; 15(7):833-852. PubMed ID: 32345066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection-based discovery of druglike macrocyclic peptides.
    Passioura T; Katoh T; Goto Y; Suga H
    Annu Rev Biochem; 2014; 83():727-52. PubMed ID: 24580641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioactive peptides based on diversity libraries, supramolecular chemistry and rational design: a new class of peptide drugs. Introduction.
    Meloen R; Timmerman P; Langedijk H
    Mol Divers; 2004; 8(2):57-9. PubMed ID: 15209157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide Display Technologies.
    Pitt A; Nims Z
    Methods Mol Biol; 2019; 2001():285-298. PubMed ID: 31134576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving a Peptide: Library Platforms and Diversification Strategies.
    Bozovičar K; Bratkovič T
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31892275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imidazole: An Emerging Scaffold Showing its Therapeutic Voyage to Develop Valuable Molecular Entities.
    Chopra B; Dhingra AK; Prasad DN
    Curr Drug Res Rev; 2020; 12(2):103-117. PubMed ID: 31782364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction to biological complexity as a missing link in drug discovery.
    Gintant GA; George CH
    Expert Opin Drug Discov; 2018 Aug; 13(8):753-763. PubMed ID: 29871539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is phage display technology on target for developing peptide-based cancer drugs?
    Landon LA; Zou J; Deutscher SL
    Curr Drug Discov Technol; 2004 Jun; 1(2):113-32. PubMed ID: 16472251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Medicinal Chemistry of Therapeutic Peptides: Recent Developments in Synthesis and Design Optimizations.
    Parthasarathy A; Anandamma SK; Kalesh KA
    Curr Med Chem; 2019; 26(13):2330-2355. PubMed ID: 29022499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cone snail venomics: from novel biology to novel therapeutics.
    Prashanth JR; Brust A; Jin AH; Alewood PF; Dutertre S; Lewis RJ
    Future Med Chem; 2014 Oct; 6(15):1659-75. PubMed ID: 25406006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current parallel chemistry principles and practice: application to the discovery of biologically active molecules.
    Edwards PJ
    Curr Opin Drug Discov Devel; 2009 Nov; 12(6):899-914. PubMed ID: 19894197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current directions in the evolution of compound libraries.
    Webb TR
    Curr Opin Drug Discov Devel; 2005 May; 8(3):303-8. PubMed ID: 15892244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons learnt from assembling screening libraries for drug discovery for neglected diseases.
    Brenk R; Schipani A; James D; Krasowski A; Gilbert IH; Frearson J; Wyatt PG
    ChemMedChem; 2008 Mar; 3(3):435-44. PubMed ID: 18064617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioactive peptides from libraries.
    Falciani C; Lozzi L; Pini A; Bracci L
    Chem Biol; 2005 Apr; 12(4):417-26. PubMed ID: 15850978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinatorial drug discovery: which methods will produce the greatest value?
    Ecker DJ; Crooke ST
    Biotechnology (N Y); 1995 Apr; 13(4):351-60. PubMed ID: 9634776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.